A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab AGE: 18-75 SEVERITY: Moderate to severe LOCATION: US Only View Details
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) AGE: 18+ SEVERITY: Moderate to severe LOCATION: International View Details
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) (CEDAR) AGE: 18-80 SEVERITY: Moderate or severe LOCATION: US Only View Details
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% AGE: 18+ SEVERITY: Mild to moderate LOCATION: US Only View Details
Aviclear for Hidradenitis Suppurativa (HS) AGE: 18-60 HURLEY STAGE: I & II LOCATION: US Only View Details
A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with Moderate to Severe Hidradenitis Suppurativa AGE: 18+ HURLEY STAGE: II & III LOCATION: US Only View Details
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa AGE: 18+ HURLEY STAGE: II & III LOCATION: US Only View Details
Myriad™ Augmented Soft Tissue Reconstruction Registry AGE: 18+ HURLEY STAGE: All LOCATION: US Only View Details
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers AGE: 18+ HURLEY STAGE: All LOCATION: International View Details
Regulation of Inflammatory Genes in Hidradenitis Suppurativa AGE: 18+ HURLEY STAGE: All LOCATION: US Only View Details